
Early-stage B2B venture capital firm backed by experienced enterprise operators who invest alongside it

Transatlantic venture firm building early-stage life science companies in emerging hubs

Epidarex Capital is a transatlantic venture capital firm led by a team of early-stage investors. It builds life science companies in emerging hubs, using its scientific and industry networks.
The firm positions itself as a partner to founders and to co-investors. Its news feed shows portfolio companies announcing board appointments, including Kynos Therapeutics in Edinburgh and Dunad Therapeutics.
Founders of life science businesses in emerging hubs and the co-investors who back them alongside the firm.
Summary written by TrustList from the business's own published information, Oct 2026.
2 images - click to enlarge
As of 2026-10-30. Organic ranks only; sponsored placements are never ranks.
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Epidarex Capital.
Similar listings buyers compare against this one.

Early-stage B2B venture capital firm backed by experienced enterprise operators who invest alongside it

Member-based investor group funding early-stage companies through monthly review and a chapter roadshow

Venture capital firm backing pre-seed deep technology startups in health and planetary sustainability

Venture capital firm partnering with founders from first idea through to public listing

Silicon Valley venture capital firm investing from seed to growth stage across technology sectors

Moroccan institutional fund investing in technology start-ups with high growth potential
Everything here links back to the same verified catalogue. Pick your next stop.